SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc., (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM), announced today that it has received U.S. Food and Drug Administration (FDA) approval for ...

テルモ株式会社（本社:東京都渋谷区、社長:佐藤 慎次郎）は、本日2月28日、持続血糖測定器「Dexcom G4 PLATINUMシステム」（デクスコム G4 プラチナムシステム）を、全国の医療機関に向けて発売しました。本製品は、持続血糖測定器で世界トップシェアの米国デ ...

DexCom’s shares shot up as much as 8% in the trading session following the announcement. The stock has been up 2.6% since the news release. Currently, the DexCom G4 PLATINUM (Pediatric) is the only ...

Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...

, a leader in continuous glucose monitoring, announced today that the U.S. Food and Drug Administration has approved its eagerly anticipated new continuous glucose monitoring system, the Dexcom G4™ ...

The Dexcom G4 receiver, which will have an "identical" form factor to the forthcoming Bluetooth version. In a call to investors days after its app won FDA approval, Dexcom CEO Kevin Sayer shared some ...

Dexcom has announced it has received FDA approval of a new continuous glucose monitoring system, according to a news release. The Dexcom G4 PLATINUM system consists of three parts: a sensor, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The Julphar revolutionary real-time continuous glucose monitoring device (CGM), Dexcom G4 Platinum is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and ...